Isogenica operates a range of discovery platforms supported by state-of-the-art methodologies for identifying antibody and peptide ligands.

Biotechnology

Health Care

Life Sciences

Isogenica

Bill Eldridge

David Mead

Lurdes Duarte

The Research and Development team at Isogenica focuses on leveraging advanced methodologies to discover and optimize antibody and peptide ligands. They conduct experiments, develop assays, and innovate new strategies to improve the efficacy and accuracy of ligand identification, supporting the company's mission to advance biotherapeutic discovery.

Research and Development

About

Team members